 VICTORIA, British Columbia--BUSINESS WIRE--- IPA AI--IPA IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA NASDAQ: IPA TSXV: IPA, an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss its financial results and recent business highlights for fourth quarter and full fiscal year 2022, on Friday, July 29, 2022, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. ImmunoPrecise man 